Sign Up for On-Demand Videos

Health
in Motion

All Systems Go

Plan Your Day

Abbott Hub Sessions at TCT 2023

Hub Hours
  • Tuesday, October 24 from 11:00 a.m. – 6:00 p.m.
  • Wednesday, October 25 from 9:00 a.m. – 6:00 p.m.
  • Thursday, October 26 from 9:00 a.m. – 4:00 p.m.

Tuesday, October 24

9:45 am – 9:55 am
Medtech Innovation

Robert Ford: Artificial Intelligence in Medtech Innovation

Moscone South | Exhibit Level | Innovation & Clinical Science Theater
Add to Calendar
10:00 a.m. – 10:08 a.m.
PCI

xDAPT: An AI Developed Individualized DAPT Model Using Data from XIENCE Trials

Moscone South | Exhibit Level | Innovation & Clinical Science Theater
Add to Calendar
11:00 a.m.– 12:00 p.m.
Transcatheter Mitral

Driven by Design: The Engineering & Evidence Behind 20 Years of MitraClip™ Therapy

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenters: Jason Rogers, MD; Paul Mahoney, MD, and Steven Bolling, MD

Next-Level Engagement: Talk with Abbott engineers about design features unique to MitraClip™ therapy

Important Safety Information

1:00 p.m. – 2:00 p.m.
Physiology

Coronary Microvascular Dysfunction: Clarifying the Confusion on the Microcirculation

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenters: Samit Shah, MD; Allen Jeremias, MD

Next-Level Engagement: Discussion on the importance of CMD testing and how to interpret and assess results

2:18 p.m. – 2:29 p.m.
Transcatheter Mitral

TENDYNE™ SUMMIT Pivotal Trial Roll-in and MAC Arm Outcomes

Moscone South | Innovation & Clinical Science Theater | Hall B
Add to Calendar

Presenters: Jason H. Rogers, MD; Vinod H. Thourani, MD

Caution: TENDYNE™ is an investigational device. Limited by Federal (U.S.) law to investigational use only and not available for sale.

2:36 p.m.– 2:54 p.m.
Transcatheter Tricuspid

TRILUMINATE™ Pivotal Trial: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Moscone South | Innovation & Clinical Science Theater | Hall B
Add to Calendar

Presenter: David H. Adams, MD

CAUTION: Investigational Device. Limited by Federal (U.S.) law to investigational use only.

3:00 p.m. – 4:00 p.m.
Intravascular Imaging

The Future of Imaging with ULTREON™ 2.0 Software

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenters: Richard Shlofmitz, MD; Ziad Ali, MD

Next-Level Engagement: A hands-on workshop showing the advancement of Ultreon 2.0 Software vs. AptiVue Imaging Software

Important Safety Information

3:12 p.m. – 3:30 p.m.
Transcatheter Mitral

One-Year Outcomes with Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair from EXPAND G4 Late-Breaking Science

Moscone South | Innovation & Clinical Science Theater | Hall B
Add to Calendar

Presenter: Ralph Stephan von Bardeleben, MD, PhD

3:30 p.m.
TAVI

LIVE Case: University of Pittsburgh Medical Center, Pittsburgh, PA - TAVR

Moscone North | Structural Theater | Hall F | Exhibit Level
Add to Calendar

Presenter: Ibrahim Sultan, MD, FACS, FACC

5:00 p.m. – 5:30 p.m.
TAVI | Vessel Closure

Access-Site Management for TAVI: Why Suture-Mediated Closure is My First Choice

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenter: Rahul Sharma, MBBS, FRACP

Next-Level Engagement: Hands-on deployment of Perclose™ ProStyle™ Device

Important Safety Information

5:30 p.m. – 6:00 p.m.
TAVI

The Future of TAVI and the ENVISION Trial

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenter: Rishi Puri, MD

Next-Level Engagement: Discussions around ENVISION Trial with steering committee

Wednesday, October 25

9:00 a.m.– 10:00 a.m.
Thrombectomy

JETi™ Hydrodynamic Thrombectomy: A Dual-Action Design for Efficient Clot Removal

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenter: Mehdi Shishehbor, MD

Next-Level Engagement: Hands-on simulation of clot removal with JETi™ Hydrodynamic Thrombectomy System

Important Safety Information

11:00 a.m. – 12:00 p.m.
Intravascular Imaging

Simplify the Complex With OCT

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenters: Gregg Stone, MD; Ajay Kirtane, MD

11:00 a.m. – 11:21 a.m.
Endovascular

Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial

Moscone South | Innovation & Clinical Science Theater | Hall B
Add to Calendar

Presenter: Ramon L. Varcoe, MBBS, MS, PhD, MMed

Caution: Esprit™ BTK Everolimus Eluting Resorbable Scaffold System is an investigational device. Limited by Federal (U.S.) law to investigational use only and not available for sale.

1:00 p.m. – 2:00 p.m.
Endovascular

Drug-Coated Balloons – Time to Unveil What You’re Not Seeing

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenter: Kenneth Rosenfield, MD

Next-Level Engagement: Get your badge scanned to receive updates on the SurVeil Drug-Coated Balloon

Important Safety Information

2:00 p.m. – 3:00 p.m.
Orbital Atherectomy

Orbital Atherectomy Symposium - “A Global Perspective On Procedural Strategies For Severely Calcified Lesions”

Moscone South | Level 2 | Presentation Theater 1
Add to Calendar

Presenters: Hayder Hashim, MD (Moderator); Jennifer Rymer, MD; Jacques Monsegu, MD, PhD; Takashi Ashikaga, MD; Naresh Solankhi, MD; Ravi Sharma, MD

3:00 p.m. – 4:00 p.m.
Intravascular Imaging

Identifying and Managing Calcified Lesions

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenters: Evan Shlofmitz, MD; Kathleen Kearney, MD

Next-Level Engagement: Interactive session, with live product demo, describing the role of OCT and orbital atherectomy in assessing and managing calcified lesions

3:43 p.m. – 3:50 p.m.
Transcatheter Tricuspid

TRILUMINATE™ Pivotal Imaging Sub-study: Insights from CT and MRI

Moscone South | Innovation & Clinical Science Theater | Hall B
Add to Calendar

Presenter: João L. Cavalcante, MD

CAUTION: Investigational Device. Limited by Federal (U.S.) law to investigational use only.

4:00 p.m. – 5:00 p.m.
Endovascular

Expanding and Implementing Health Equity in Clinical Trials – Impact on Diversity and Inclusion

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenters: Jennifer Jones-McMeans; Sahil A. Parikh, MD; Natalia Pinilla-Echeverri, MD; Danielle R. Bajakian, MD; Megan Coylewright, MD; Akilah Cadet; Jennifer Meinen (Moderator)

Next-Level Engagement: Discussions around expanding and implementing healthy equity in clinical trials

5:00 p.m. – 6:00 p.m.
Endovascular

LIFE-BTK Office Hours

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenters: Ramon Varcoe, MBBS, MS, PhD, MMed;, Brian DeRubertis, MD, FACS;, Sahil Parikh, MD, FSCAI;, Danielle Bajakian, MD;, Chris Metzger, MD; Lawrence Garcia, MD, FACC, FAHA, FSCAI

Next-Level Engagement: The LIFE-BTK Office Hours will be a time for physicians to meet with the investigators and Abbott Clinical Science and Med Affairs experts to discuss the LIFE-BTK trial results

Thursday, October 26

9:00 a.m.– 10:00 a.m.
Endovascular

Carotid Artery Stenting and the National Coverage Decision

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenter: Christopher Metzger, MD

Next-Level Engagement: Hands-on deployment of XACT™ Carotid Stent System and Emboshield NAV6™ System

Important Safety Information (XACT™ Carotid Stent System)
Important Safety Information (Emboshield NAV6™ System)

11:00 a.m. – 11:30 a.m.
TAVI

The Future of TAVI and Lifetime Management

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenters: Sahil Khera, MD, MPH

Next-Level Engagement: Interactive discussion, with the Navitor valve, sharing procedural applicability and lifetime management decisions

11:22 a.m. – 11:44 a.m.
Transcatheter Tricuspid

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients With Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE™ Pivotal Trial

Moscone South | Innovation & Clinical Science Theater | Hall B
Add to Calendar

Presenter: Suzanne V. Arnold, MD

CAUTION: Investigational Device. Limited by Federal (U.S.) law to investigational use only.

11:30 a.m.– 12:00 p.m.
LAAO

Versatility of the Amulet™ Occluder Adapting to Various LAA Morphologies

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenter: Rahul Sharma, MBBS, FRACP

Next-Level Engagement: Discussion around the Amulet occluder’s versatility in a broad range of LAA morphologies and a product demo

Important Safety Information

1:00 p.m. – 2:00 p.m.
Intravascular Imaging

Review of the Latest OCT Data and AI-Driven Solution

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenter: Evan Shlofmitz, MD

Next-Level Engagement: Discussions around the usage of AI, OCT and imaging data

3:00 p.m. – 4:00 p.m.
PCI

XIENCE™ Stent System: The use of Clinical Evidence and Artificial Intelligence (AI) to Personalize DAPT Treatment Regimen

Abbott HUB #3 Theater | Exhibit Hall
Add to Calendar

Presenters: Roxana Mehran, MD; Hirotoshi Watanabe, MD

Next-Level Engagement: Discussions around the usage of AI to personalize DAPT regimen

Important Safety Information

Indications
Applies to XIENCE Skypoint™, XIENCE Sierra™ and XIENCE Alpine™ Stent Systems:
  • Indicated for improving coronary artery luminal diameter in patients, including those at high risk for bleeding and those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary artery lesions (length ≤ 32 mm) with reference vessel diameters of ≥ 2.25 mm to ≤ 4.25 mm.
  • Treating de novo chronic total coronary occlusions.

In addition, XIENCE Skypoint™ Stent System is indicated with reference vessel diameters of ≥ 2.25 mm to ≤ 5.25 mm.